HIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation

Abstract Adverse birth outcomes are common in HIV-positive pregnant women receiving combination antiretroviral therapy (cART), especially when cART is initiated in early pregnancy. The mechanisms remain poorly understood. Using a mouse model we demonstrate that protease inhibitor based-cART exposure...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hakimeh Mohammadi, Eszter Papp, Lindsay Cahill, Monique Rennie, Nicole Banko, Lakmini Pinnaduwage, Janice Lee, Mark Kibschull, Caroline Dunk, John G. Sled, Lena Serghides
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/37bf226f60dd4bb08d817725f3d25913
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:37bf226f60dd4bb08d817725f3d25913
record_format dspace
spelling oai:doaj.org-article:37bf226f60dd4bb08d817725f3d259132021-12-02T15:09:00ZHIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation10.1038/s41598-018-24680-w2045-2322https://doaj.org/article/37bf226f60dd4bb08d817725f3d259132018-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-24680-whttps://doaj.org/toc/2045-2322Abstract Adverse birth outcomes are common in HIV-positive pregnant women receiving combination antiretroviral therapy (cART), especially when cART is initiated in early pregnancy. The mechanisms remain poorly understood. Using a mouse model we demonstrate that protease inhibitor based-cART exposure beginning on day 1 of pregnancy was associated with a pro-angiogenic/pro-branching shift in the placenta driven by lower Flt-1 levels and higher Gcm-1 expression. Micro-CT imaging revealed an increase in the number of arterioles in cART-treated placentas, which correlated with fetal growth restriction. Delaying initiation of cART, or supplementing cART-treated mice with progesterone, prevented the pro-angiogenic/pro-branching shift and the associated placenta vascular changes. In agreement with our mouse findings, we observed an increase in the number of terminal-villi capillaries in placentas from HIV-positive cART-exposed women compared to HIV-negative controls. Capillary number was inversely correlated to maternal progesterone levels. Our study provides evidence that cART exposure during pregnancy influences placenta vascular formation that may in turn contribute to fetal growth restriction. Our findings highlight the need for closer investigation of the placenta in HIV-positive pregnancies, particularly for pregnancies exposed to cART from conception, and suggest that progesterone supplementation could be investigated as a possible intervention to improve placenta function in HIV-positive pregnant women.Hakimeh MohammadiEszter PappLindsay CahillMonique RennieNicole BankoLakmini PinnaduwageJanice LeeMark KibschullCaroline DunkJohn G. SledLena SerghidesNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-14 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hakimeh Mohammadi
Eszter Papp
Lindsay Cahill
Monique Rennie
Nicole Banko
Lakmini Pinnaduwage
Janice Lee
Mark Kibschull
Caroline Dunk
John G. Sled
Lena Serghides
HIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation
description Abstract Adverse birth outcomes are common in HIV-positive pregnant women receiving combination antiretroviral therapy (cART), especially when cART is initiated in early pregnancy. The mechanisms remain poorly understood. Using a mouse model we demonstrate that protease inhibitor based-cART exposure beginning on day 1 of pregnancy was associated with a pro-angiogenic/pro-branching shift in the placenta driven by lower Flt-1 levels and higher Gcm-1 expression. Micro-CT imaging revealed an increase in the number of arterioles in cART-treated placentas, which correlated with fetal growth restriction. Delaying initiation of cART, or supplementing cART-treated mice with progesterone, prevented the pro-angiogenic/pro-branching shift and the associated placenta vascular changes. In agreement with our mouse findings, we observed an increase in the number of terminal-villi capillaries in placentas from HIV-positive cART-exposed women compared to HIV-negative controls. Capillary number was inversely correlated to maternal progesterone levels. Our study provides evidence that cART exposure during pregnancy influences placenta vascular formation that may in turn contribute to fetal growth restriction. Our findings highlight the need for closer investigation of the placenta in HIV-positive pregnancies, particularly for pregnancies exposed to cART from conception, and suggest that progesterone supplementation could be investigated as a possible intervention to improve placenta function in HIV-positive pregnant women.
format article
author Hakimeh Mohammadi
Eszter Papp
Lindsay Cahill
Monique Rennie
Nicole Banko
Lakmini Pinnaduwage
Janice Lee
Mark Kibschull
Caroline Dunk
John G. Sled
Lena Serghides
author_facet Hakimeh Mohammadi
Eszter Papp
Lindsay Cahill
Monique Rennie
Nicole Banko
Lakmini Pinnaduwage
Janice Lee
Mark Kibschull
Caroline Dunk
John G. Sled
Lena Serghides
author_sort Hakimeh Mohammadi
title HIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation
title_short HIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation
title_full HIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation
title_fullStr HIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation
title_full_unstemmed HIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation
title_sort hiv antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/37bf226f60dd4bb08d817725f3d25913
work_keys_str_mv AT hakimehmohammadi hivantiretroviralexposureinpregnancyinducesdetrimentalplacentavascularchangesthatarerescuedbyprogesteronesupplementation
AT eszterpapp hivantiretroviralexposureinpregnancyinducesdetrimentalplacentavascularchangesthatarerescuedbyprogesteronesupplementation
AT lindsaycahill hivantiretroviralexposureinpregnancyinducesdetrimentalplacentavascularchangesthatarerescuedbyprogesteronesupplementation
AT moniquerennie hivantiretroviralexposureinpregnancyinducesdetrimentalplacentavascularchangesthatarerescuedbyprogesteronesupplementation
AT nicolebanko hivantiretroviralexposureinpregnancyinducesdetrimentalplacentavascularchangesthatarerescuedbyprogesteronesupplementation
AT lakminipinnaduwage hivantiretroviralexposureinpregnancyinducesdetrimentalplacentavascularchangesthatarerescuedbyprogesteronesupplementation
AT janicelee hivantiretroviralexposureinpregnancyinducesdetrimentalplacentavascularchangesthatarerescuedbyprogesteronesupplementation
AT markkibschull hivantiretroviralexposureinpregnancyinducesdetrimentalplacentavascularchangesthatarerescuedbyprogesteronesupplementation
AT carolinedunk hivantiretroviralexposureinpregnancyinducesdetrimentalplacentavascularchangesthatarerescuedbyprogesteronesupplementation
AT johngsled hivantiretroviralexposureinpregnancyinducesdetrimentalplacentavascularchangesthatarerescuedbyprogesteronesupplementation
AT lenaserghides hivantiretroviralexposureinpregnancyinducesdetrimentalplacentavascularchangesthatarerescuedbyprogesteronesupplementation
_version_ 1718387931031273472